{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:32:12Z","timestamp":1762918332733,"version":"3.45.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cjco.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T07:50:31Z","timestamp":1657266631000},"page":"823-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-2488","authenticated-orcid":false,"given":"Kenan","family":"Yalta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertan","family":"Yetk\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2022.07.003_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cjco.2021.12.009","article-title":"Multiple \u0131ntramyocardial masses in an otherwise healthy 35-year-old woman","volume":"4","author":"Powell","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2022.07.003_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2022.07.003_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pcad.2008.10.001","article-title":"Risks and challenges of implantable cardioverter-defibrillators in young adults","volume":"51","author":"Sherrid","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjco.2022.07.003_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/heartjnl-2021-320244","article-title":"Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis","volume":"108","author":"Yoshitomi","year":"2022","journal-title":"Heart"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X22001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X22001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:09:17Z","timestamp":1762902557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X22001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":4,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2589790X22001299"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2022.07.003","relation":{},"ISSN":["2589-790X"],"issn-type":[{"type":"print","value":"2589-790X"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2021.12.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}